Piramal Pharma Ltd. (PPLPHARMA): Piramal Pharma Share Price rises 2.35% to Rs 209.3; market cap at Rs 26,939.83 crore
- September 18, 2026
- Posted by: Harsh Piplani
- Category: News
Piramal Pharma Share Price rose today, with the stock closing at Rs 209.3, up 2.35% from the previous close of Rs 204.5. The company’s market capitalisation stood at Rs 26,939.83 crore, keeping Piramal Pharma Ltd. in focus in Healthcare and Pharmaceuticals & Drugs on NSE and BSE. The move is relevant because it adds a fresh same-day share price gain to Piramal Pharma Stock News, even though the supplied data does not establish a company-specific catalyst. Univest tracks the verified price action, valuation and sector context so readers can place today’s update in a broader market framework. For investors scanning Piramal Pharma Share Price Today, the main questions are simple: what changed in the session, how does the valuation compare with peers, and what do the reported financial ratios say about the company’s current profile? Univest answers those questions with only verified data and without drawing on any unreported trigger, announcement or forecast.
Piramal Pharma Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 209.3 |
| Previous Close | Rs 204.5 |
| Today's Move | Rs 4.8 (+2.35%) |
| Open | Rs 204.8 |
| High | Rs 210 |
| Low | Rs 204.6 |
| Turnover | Rs 2.3 crore |
| Market Capitalisation | Rs 26,939.83 crore |
| Market Cap Category | Large Cap |
Piramal Pharma Ltd. (PPLPHARMA) rose to Rs 209.3 from the previous close of Rs 204.5, a move of Rs 4.8 or 2.35%. The stock opened at Rs 204.8, reached a high of Rs 210, recorded a low of Rs 204.6.
Piramal Pharma Ltd. (PPLPHARMA) rose to Rs 209.3 from the previous close of Rs 204.5, a move of Rs 4.8 or 2.35%. The stock opened at Rs 204.8, reached a high of Rs 210, and recorded a low of Rs 204.6. That path shows that the price stayed within a fairly tight band for most of the session before ending close to the day’s high.
Piramal Pharma Share Price Today therefore reflects a steady intraday gain rather than a sharp re-pricing. The session began just above the prior close, moved up to Rs 210, and settled at Rs 209.3, leaving the stock near the upper end of its visible range. Turnover stood at Rs 2.3 crore, which gives a basic sense of trading interest without implying anything beyond the verified update. For readers following Piramal Pharma Stock News, the key takeaway is that the stock ended stronger on the day, but the supplied data does not identify the exact driver behind the move. The market cap of Rs 26,939.83 crore adds size context to the price action and helps frame the stock’s place in the sector.
Piramal Pharma Ltd. (PPLPHARMA) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 26,939.83 crore |
| P/B Ratio | 3.4x |
| ROE | -4.04% |
| ROCE | 1.24% |
| EPS | Rs -2.36 |
| Book Value Per Share | Rs 60.13 |
| Dividend Yield | 0% |
Piramal Pharma Ltd. (PPLPHARMA) fundamental metrics show P/B 3.4x, ROE -4.04%, ROCE 1.24%. These figures provide context only and are not a buy or sell signal.
Piramal Pharma Ltd. has a market capitalisation of Rs 26939.83 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/B at 3.4x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of -4.04% and ROCE of 1.24%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs -2.36, book value per share of Rs 60.13, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.69x, median ROE of 11.78%, median ROCE of 13.65%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Benchmark Median P/E | 32.69x |
| Benchmark Average P/E | 44.72x |
| Benchmark P/E Range | 3.44x to 417.17x |
| Company P/B Ratio | 3.4x |
| Benchmark Median P/B | 3.1x |
| Company ROE | -4.04% |
| Benchmark Median ROE | 11.78% |
| Company ROCE | 1.24% |
| Benchmark Median ROCE | 13.65% |
| Company Market Capitalisation | Rs 26,939.83 crore |
| Benchmark Median Market Cap | Rs 741.38 crore |
Piramal Pharma Ltd. (PPLPHARMA) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Piramal Pharma Ltd. (PPLPHARMA) has a ROE of -4.04%, which is below the benchmark median of 11.78%, a difference of -134.3%. Piramal Pharma Ltd. (PPLPHARMA) has a ROCE of 1.24%, which is below the benchmark median of 13.65%, a difference of -90.92%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,44,716.74 | 37.01 | 5.18 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,44,223.13 | 84.83 | 14.05 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,83,453.32 | 85.3 | 20.73 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,10,224.17 | 25.14 | 4.21 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,09,848.55 | 32.89 | 3.15 | 11.83 | 16 |
Its ROE of -4.04% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 1.24% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Piramal Pharma Ltd. (PPLPHARMA) has a market capitalisation of Rs 26,939.83 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Piramal Pharma
- Piramal Pharma Share Price rose 2.35% today to Rs 209.3 after opening at Rs 204.8.
- The stock’s day range was Rs 204.6 to Rs 210, with turnover of Rs 2.3 crore.
- Market capitalisation stood at Rs 26,939.83 crore in the latest update.
- P/B ratio was 3.4, compared with the sector median of 3.1 and average of 4.36.
- ROE was -4.04 and ROCE was 1.24, both below the same-industry benchmark medians.
About Piramal Pharma
Piramal Pharma Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied data does not break out business segments, revenue mix or product categories, so the company overview here stays within the verified snapshot. What is clear is that Piramal Pharma is a listed pharmaceutical business with a market capitalisation of Rs 26,939.83 crore, which places it well above the industry median in the same-industry benchmark set. Its reported book value is Rs 60.13 per share, EPS is -2.36, ROE is -4.04 and ROCE is 1.24. These figures help frame the company’s position in the market. For readers tracking Piramal Pharma Stock Performance, the stock’s current share price event sits alongside a business profile that reflects scale, sector membership and a mixed profitability profile. Univest publishes this company context to support factual Piramal Pharma Company News and Piramal Pharma Stock News reading.
Track Piramal Pharma Share Price on Univest
Use Piramal Pharma Ltd. (PPLPHARMA) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Readers can track Piramal Pharma Share Price on Univest for live share price updates, key financial ratios, shareholding pattern, 52-week levels and market insights. Univest also brings together Piramal Pharma Share Price Today, Piramal Pharma Stock Analysis and Piramal Pharma Fundamental Analysis in one place so the latest data is easier to review. The platform keeps the focus on verified figures, so users can follow the stock’s latest movement, valuation context and company overview without relying on unverified claims. If you are scanning Piramal Pharma Share Price Live or Piramal Pharma Latest News, Univest provides a clean way to monitor the same company, sector and peer data used in this article.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Piramal Pharma Share Price rise today?
Ans. Piramal Pharma Share Price rose 2.35% to Rs 209.3 today, but the supplied data does not establish a company-specific catalyst. The verified session shows the price move, opening range, high, low and turnover only.
What is Piramal Pharma Share Price today?
Ans. Piramal Pharma Share Price today is Rs 209.3. The stock gained Rs 4.8, or 2.35%, from the previous close of Rs 204.5 and finished near the day’s high of Rs 210.
What is Piramal Pharma’s market capitalisation?
Ans. Piramal Pharma’s market capitalisation is Rs 26,939.83 crore in the supplied update. That is materially above the same-industry median of Rs 741.38 crore and above the benchmark average of Rs 13,917.82 crore.
How does Piramal Pharma compare with peers on valuation?
Ans. Piramal Pharma’s P/B ratio is 3.4. That is below Sun Pharma, Divi's Laboratories and Torrent Pharmaceuticals, but above Cipla and slightly below Zydus Lifesciences in the supplied peer set. Its P/B ratio is 3.4x.
What do Piramal Pharma’s ROE and ROCE show?
Ans. Piramal Pharma reports ROE of -4.04 and ROCE of 1.24. Both sit below the same-industry benchmark medians, so the returns snapshot remains weaker than the sector norm in this data set.
Does Piramal Pharma pay a dividend?
Ans. The dividend yield supplied for Piramal Pharma is 0. That means the current snapshot does not show a dividend contribution, while book value stands at Rs 60.13 per share and EPS is -2.36.
